Cooper Companies (NASDAQ:COO) Director Lawrence Erik Kurzius Buys 10,000 Shares

Posted by George Bondi on Sep 16th, 2026

The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) Director Lawrence Kurzius acquired 10,000 shares of the business’s stock in a transaction dated Monday, September 14th. The stock was acquired at an average price of $53.91 per share, for a total transaction of $539,100.00. Following the purchase, the director directly owned 21,099 shares of the company’s stock, valued at approximately $1,137,447.09. This trade represents a 90.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Cooper Companies Trading Down 1.8%

NASDAQ COO opened at $53.27 on Wednesday. The Cooper Companies, Inc. has a 1 year low of $51.01 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73. The company has a market capitalization of $10.13 billion, a PE ratio of 18.18, a P/E/G ratio of 2.21 and a beta of 0.82. The company has a fifty day moving average of $70.88 and a 200 day moving average of $69.19.

Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.The firm’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the firm earned $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 4.53 earnings per share for the current year.

Cooper Companies announced that its board has approved a stock repurchase program on Wednesday, September 9th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the medical device company to purchase up to 22.7% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its shares are undervalued.

More Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

Positive Sentiment: Three Cooper Companies directors reported approximately $1.33 million in combined stock purchases. Paul A. Keel bought 4,701 shares for roughly $250,000, Lawrence Kurzius purchased 10,000 shares for $539,100, and Walter M. Rosebrough Jr. acquired 10,000 shares across two transactions for approximately $541,640. The purchases may indicate that company insiders view the recent selloff as excessive. SEC insider purchase filing
Positive Sentiment: An analysis titled “A Little More Compelling At This Price” suggests COO’s valuation has become more attractive following the decline, potentially supporting interest from value-oriented investors. Seeking Alpha analysis
Neutral Sentiment: Rosen Law Firm announced an investigation into potential securities claims involving allegations that Cooper Companies may have issued materially misleading business information. The announcement does not establish wrongdoing, but it adds legal and headline risk for shareholders. Rosen Law Firm announcement
Negative Sentiment: Cooper Companies reduced fiscal 2026 adjusted EPS guidance to $4.51–$4.55 from $4.58–$4.66 and cut revenue guidance to $4.23–$4.25 billion from $4.29–$4.32 billion. The revisions reflect weaker-than-expected contact-lens demand, particularly at CooperVision. Insider Monkey report
Negative Sentiment: Reports indicated that third-quarter results included U.S. channel inventory destocking and other negative surprises, contributing to the sharp decline in COO shares. Investors are likely focused on how quickly distributors normalize inventories and whether underlying demand improves. HBSS report

Wall Street Analyst Weigh In

Several equities research analysts have commented on COO shares. UBS Group lowered their price objective on Cooper Companies from $75.00 to $66.00 and set a “neutral” rating on the stock in a research report on Thursday, September 10th. JPMorgan Chase & Co. cut their target price on shares of Cooper Companies from $71.00 to $58.00 and set a “neutral” rating for the company in a report on Thursday, September 10th. Stifel Nicolaus set a $70.00 target price on shares of Cooper Companies and gave the company a “buy” rating in a research note on Thursday, September 10th. BNP Paribas Exane lowered their price target on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a report on Monday, June 8th. Finally, Zacks Research lowered shares of Cooper Companies from a “hold” rating to a “strong sell” rating in a research report on Friday, September 11th. Five investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $71.47.

Check Out Our Latest Stock Analysis on Cooper Companies

Hedge Funds Weigh In On Cooper Companies

A number of hedge funds have recently bought and sold shares of COO. Algert Global LLC acquired a new position in Cooper Companies during the second quarter worth $7,655,000. BlackRock Inc. acquired a new stake in shares of Cooper Companies in the 2nd quarter worth $1,077,762,000. Heartland Advisors Inc. acquired a new stake in shares of Cooper Companies in the 4th quarter worth $15,348,000. Tocqueville Asset Management L.P. purchased a new position in shares of Cooper Companies during the 2nd quarter worth $1,502,000. Finally, National Pension Service raised its holdings in shares of Cooper Companies by 9,314.0% during the 2nd quarter. National Pension Service now owns 526,149 shares of the medical device company’s stock worth $37,730,000 after acquiring an additional 520,560 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

About Cooper Companies

(Get Free Report)

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.